Signal transduction pathways induced by cytokines can modulate the level of HIV-1 gene transcription and replication in a variety of cells including those from the central nervous system. Here, we investigated the effect of TGF␤-1 signaling the factors, including Smads, on transcription of the viral LTR in human astrocytic cells. Ectopic expression of Smad-3 increased activity of the viral promoter, while its partner protein, Smad-4, caused a slight decrease in viral gene transcription. Further, Smad-4 was able to suppress transcriptional activation of the LTR by Smad-3 as well as by C/EBP␤, another activator of LTR transcription in these cells. Results from promoter deletion experiments identified the C/EBP-binding site, which is positioned between nucleotides Ϫ114 and Ϫ102 as one of the targets for Smad-mediated regulation of the LTR. Band-shift studies showed inhibition of C/EBP binding to its target DNA in protein extract from cells overexpressing Smad-3 and Smad-4. Results from GST pull-down assay and combined immunoprecipitation/Western blot of protein extracts from human astrocytes verified the association of Smad-3 and Smad-4 with C/EBP␤, suggesting that interaction of C/EBP␤ with Smad-3 and Smad-4 may have a negative impact upon C/EBP␤-mediated activation of the LTR. Interestingly, Smad-4 showed no inhibitory effect on viral gene transcription in cells expressing Tat protein. However, in the presence of Smad-3, expression of Smad-4 exerted a negative effect on Tat-mediated activation of the LTR promoter. These observations pointed to the functional interplay between viral and cellular proteins in modulating LTR transcription.
The HIV-1 LTR DNA sequence is composed of several distinct regulatory motifs, each exerting their role on the transcription of the viral genome by interacting with cellular DNA binding transcription factors (for review see Pereira et al., 2000) . Some of the participant transcription factors are inducible and the level of their expression and/or activities in cells is regulated by external stimuli such as cytokines and immunomodulators (Atwood et al., 1994; Kumar et al., 1996) . Several inflammatory cytokines such as interleukin 1 (IL-1), tumor necrosis factor ␣ (TNF␣), and transforming growth factor ␤ (TGF␤) whose levels are elevated in patients with AIDS (Tyor et al., 1992) have the capacity to mediate activation of several cellular and viral genes through distinct signaling pathways (Corley, 2000; Jeeninga et al., 2000; Li et al., 1998) . For example, TNF␣ and IL-1, through the IB/NFB pathway, mediate nuclear transportation of p50 and p65 subunits of NFB where they bind to the B DNA motif and stimulate transcription of the corresponding genes (Arenzana-Seisdedos et al., 1995; Beg et al., 1993) . The TGF␤-1 pathway, on the other hand, operates through the Smad family of transcription factors that transmits signals from TGF␤-1 receptors to target genes in the nu-cleus (Heldin et al., 1997; Piek et al., 1999) . For instance, the interaction of Smad-3 and Smad-4 results in nuclear import of this heterodimer and association of Smad-3: Smad-4 with the promoter DNA sequences and/or other regulatory proteins controls transcription of a distinct set of target genes (Xiao et al., 2000; Zhang et al., 1998) .
In previous studies, we and others have demonstrated an enhanced level of several critical cytokines, particularly TGF␤-1, upon expression of HIV-1 infection of astrocytes and other cells, or treatment of these cells with Tat protein (Cupp et al., 1993; Gallo et al., 1989; Lotz et al., 1990; Poli and Fauci, 1992; Rasty et al., 1996; Sawaya et al., 1998; Thatikunta et al., 1997; Wahl et al., 1991; Zauli et al., 1992) . Interestingly, some of these cytokines can regulate HIV-1 replication in various cells including monocytic/macrophage and glial cells (Lazdins et al., 1991; Poli et al., 1991; Vitkovic and da Cunha, 1995) . Here, we investigated the regulation of LTR transcription by TGF␤-1 signaling pathway to gain some information on the cooperativity between various cellular proteins induced upon HIV-1 infection that may modulate viral gene expression and replication.
In the first series of experiments, we tested the effect of Smad-3 and Smad-4 on LTR promoter activity by transfection of human astrocytic cells, U-87MG. In parallel, the effect of p50 and p65 subunits of NFB on transcription of the LTR was examined. As anticipated, and in accord with previous observations (Nabel and Baltimore, 1987) , ectopic expression of p50 had a modest effect on LTR transcription, while its activator partner, p65, showed a more positive effect on the transcription of the viral promoter. Further, coexpression of p50/p65 in cells resulted in a noticeable enhancement in transcription of the HIV-1 LTR (Fig. 1) . Expression of Smad-3 caused a drastic increase in transcription of the viral promoter, whereas under similar conditions Smad-4 expression did not alter basal CAT activity. Interestingly, coexpression of Smad-3 and Smad-4 caused a substantial decrease in the transcriptional activation of the LTR by Smad-3, suggesting that the intracellular levels of these two proteins may determine the basal activity of HIV-1 gene transcription in astrocytes ( Fig. 1 ). It is important to note that the observed Smad-4-mediated inhibition of the HIV-1 LTR is not a general event, as under similar conditions, Smad-4 showed no inhibitory effect upon SV40 early promoter activity (data not shown). To investigate the effect of TGF␤-1 on the activity of Smad-3 and Smad-4 upon LTR transcription, U-87MG cells were transfected with LTR-CAT reporter construct plus Smad-3 and Smad-4 expression plasmids in the presence and absence of TGF␤-1. As shown in Fig. 2 , treatment of these cells with TGF␤-1 increased the basal level of LTR transcription (compare lanes 1 in panels A and B). Further induction of the LTR by Smad-3 was less noticeable in the TGF␤-1-treated cells (Fig. 2B ). This observation suggests that under these experimental conditions, cells may maximally respond to TGF␤-1 stimulation and that Smad-3 may exert no significant effect upon viral gene activity. On the other hand, Smad-4 was able to decrease activation of the viral promoter in TGF␤-1-treated cells.
Results from DNA-binding experiments showed no strong and specific association of Smad proteins with the viral DNA promoter sequences, suggesting that the observed regulatory event may be mediated indirectly and via interaction with other cellular proteins. Examination of various promoter deletion mutants led us to believe that the sequence downstream from Ϫ117 of the LTR may play a more important role in the observed regulatory event (data not shown). C/EBP␤ represents one of the potent DNA-binding transcriptional activators of the LTR whose binding site resides between nucleotides Ϫ114 and Ϫ102, providing a rationale to study the involvement of this protein in TGF␤-1 signaling events.
To investigate the possible cooperativity between C/EBP and TGF␤-1 pathways, we examined the functional interaction of C/EBP␤ with Smad-3 and Smad-4 in U-87MG cells transfected with the full-length LTR promoter construct. As shown in Fig. 3 , ectopic expression of C/EBP␤ enhanced the transcriptional activity of the viral full-length promoter and that both Smad-3, and to a higher level, Smad-4 were able to decrease viral gene transcription in U-87MG cells. Again, coexpression of FIG. 2. Transcriptional activity of HIV-1 LTR by Smads in cells treated with TGF␤-1. U-87MG cells were maintained in serum-free media for 4 h prior to transfection with 2 g of full-length LTR-CAT and pcDNAbased Smads expression plasmid DNAs. After transfection, cells were maintained in DMEM containing 10% Serum Plus (JRH Biosciences) in the absence (A) or presence (B) of 0.2 ng/ml TGF␤-1. CAT enzymatic activity was determined after 48 h and the percentage conversion was identified by scintillation counting.
FIG. 1. Activation of HIV-1 LTR transcription by NF-B and Smad subunits in astrocytes.
Approximately 10 5 U-87MG cells were transfected with 2 g of a plasmid containing full-length LTR DNA (Ϫ450 to ϩ80) fused to the CAT gene in the absence and presence of 5 g of plasmids expressing p50, p65, Smad-3, and Smad-4 as indicated above the lanes. These expressor plasmids were generated using pcDNA backbone. DNA concentrations were kept constant by adding empty vector DNA (pcDNA). After 48 h, CAT activity was measured and the percentage conversion of chloramphenicol to its acetylated forms was determined (as described in Cupp et al., 1993) . All CAT experiments shown in this and other figures were repeated several times and standard variations between 15 to 20% were observed.
Smad-3 and Smad-4 showed a drastic effect on viral promoter activation by C/EBP. These data suggest that TGF␤-1 signaling factors may modulate transcription of the LTR, at least in part, via the C/EBP␤ transcription factor. To exclude the involvement of a large group of transcription factors whose binding sites reside at regions upstream from the C/EBP-binding site, a deletion mutant promoter that removes the sequences between Ϫ486 and Ϫ117 and retains the region between Ϫ117 and ϩ80 which encompasses the C/EBP-binding site at positions between Ϫ114 and Ϫ102 was used in transfection assay. As shown in Fig. 3B , the activity of this deletion promoter was enhanced by C/EBP␤. While Smad-3 showed no negative effect on the C/EBP transcriptional activity, no further enhancement on viral gene transcription above the level seen by C/EBP alone was observed. As before, Smad-4 decreased LTR activity in the presence of C/EBP␤ and Smad-3. These observations suggest that the functional interplay between C/EBP and Smads may be mediated via the C/EBP-binding sites at nucleotides Ϫ114 to Ϫ102, and that Smads may determine the association of C/EBP with its target DNA. As such, in the next series of experiments, we investigated DNA-binding activity of C/EBP in the presence and absence of Smad-3 and Smad-4. Nuclear extracts from U-87MG or U-87MG transfected with C/EBP plasmid were incubated with oligonucleotide DNA probes containing the HIV-1 C/EBPbinding site. As shown in Fig. 4A , a single intense band was detected upon incubation of U-87MG protein extract with the C/EBP probe. The intensity of the band was decreased, but not abolished, in the presence of 100and 200-fold excess of mutant DNA competitor with altered nucleotides at the binding site of C/EBP. However, formation of the complex was drastically reduced in the presence of wild-type DNA competitor, suggesting the comigration of a nonspecific DNA protein complex with a similar electrophoretic mobility as the C/EBP:DNA complex. To alleviate this nonspecific background, in the next experiment, an excess amount of mutant competitor DNA (200-fold molar excess) was incubated with wildtype DNA probe in all binding reactions. As shown in Fig.  4B , the intensity of the band corresponding to C/EBP was enhanced in the cell extract that was transfected with C/EBP plasmid and overexpressed this protein (compare lanes 1 and 2), further verifying the association of C/EBP with the C/EBP DNA probe. Interestingly, the intensity of the C/EBP nucleoprotein complex was decreased in cells expressing C/EBP along with Smad-3 or Smad-4, and completely abrogated in cells coexpressing all three proteins. It should be noted that the absence of the complex was not due to an inefficient process of transfection or protein degradation. The evidence supporting this notion came from Western blot analysis using cell extracts from transfected cells and antibody against the exogenously expressed protein. The absence of alternative bands in these reactions suggests that Smad-3 and Smad-4 may inhibit interaction of C/EBP with its target DNA sequence without being associated with the C/EBP FIG. 3. Effect of Smad-3 and Smad-4 on C/EBP activation of the LTR. U-87MG cells were transfected with 2 g of full-length LTR-CAT (A) or 2 g of a plasmid containing segments of the LTR between Ϫ117 and ϩ80 fused to the CAT gene (B) in the absence or presence of 5 g plasmids expressing C/EBP, Smad-3, or Smad-4 in various combinations. It should be noted that the C/EBP expressor plasmid was generated on an MSV-based vector (Schwartz et al., 2000) . The relative CAT activity is an average of multiple experiments and presented as fold effects with a baseline (lane 1) remaining as an arbitrary unit of 1. As before, the concentration of DNA in each transfection mixture remained constant by adding empty plasmid DNA.
DNA-binding site. Thus, it is likely that communication between C/EBP and Smads may also occur independent from its target DNA sequence via protein-protein interaction.
To examine the association of C/EBP with Smad-3 and Smad-4, U-87MG cells were transiently transfected with C/EBP expression plasmid. Nuclear extract was prepared after 48 h and incubated with GST, GST-Smad-3, and GST-Smad-4 fusion proteins coupled to glutathione Sepharose beads. Bound proteins were analyzed by Western blot using anti-C/EBP antibody. As shown in Fig.  5A , C/EBP was bound by GST-Smad-4 and GST-Smad-3 plus GST-Smad-4, but not by the GST-Smad-3 alone or GST. Examination of GST-Smad-3 and GST-Smad-4 protein levels in each binding reaction by SDS-PAGE showed that equal amounts of these fusion proteins were present in each binding reaction (Fig. 5B) . In another series of experiments, cells were transfected with plasmids expressing Smad-4 alone or together with C/EBP and Smad-3. After 48 h, nuclear extracts were prepared and immunoprecipitated using the control se-rum (NS) or anti-Smad-4 and anti-C/EBP antibodies. The immunocomplexes were analyzed by SDS-PAGE followed by Western blot analysis using anti-Smad-4 antibody. As shown in Fig. 5C , the immunocomplex that was pulled down by normal serum upon incubation of the Smad-4-transfected cell extract showed no sign corresponding to Smad-4, whereas the immunocomplex obtained from the same cell extract upon incubation with anti-Smad-4 showed a strong signal corresponding to Smad-4. Incubation of protein extract from cells that overexpressed C/EBP and Smad-4 with anti-C/EBP antibody resulted in the formation of an immunocomplex that had no significant (detectable) level of Smad-4. Nevertheless, this observation led to the speculation that Smad-4 and anti-C/EBP may recognize the same epitope within C/EBP and association of one protein with C/EBP may diminish/exclude the interaction of this protein with the other one. Interestingly, coproduction of Smad-3 and -4 together in cells expressing C/EBP alleviated this problem and the observed complex which was pulled down by anti-C/EBP antibody showed a band corresponding to Smad-4. These data suggest the interaction of Smad-4 with C/EBP in cell extracts containing both proteins. Indeed, one may also speculate that the efficient in vivo interaction of C/EBP with Smad-4 requires the presence of Smad-3. Support for this notion comes from band-shift data, where the association of C/EBP with its target DNA was completely abrogated in the presence of both Smad-3 and -4, implying that the interaction of Smad-3 and Smad-4 with C/EBP dissociates this protein from its DNA consensus motif. Altogether these observations strongly suggest that C/EBP associates with Smads and such an interaction, either in the presence or absence of DNA, may modulate C/EBP activity on the basal LTR transcription.
As the basal transcription of the LTR is enhanced by the viral transactivator, Tat, in the next series of experiments, we investigated the effects of Smad-3 and Smad-4 on Tat activation of the full-length LTR promoter construct. As shown in Fig. 6 , the basal activity of the LTR (Ϫ450 to ϩ80) was significantly enhanced by Tat in U-87MG (compare lanes 1 and 2 in panels A and B) . Inclusion of Smad-3 in transfection enhanced overall transcription of the LTR promoter construct. Interestingly, expression of Smad-4 slightly elevated the level of LTR transcription in the presence of Tat suggesting that Tat, by cooperating with Smad-4, may alleviate the negative activity of Smad-4 upon viral gene transcription. However, coproduction of Smad-3 and Smad-4 decreased the overall level of Tat-mediated transcription of the LTR, again suggesting that intracellular levels of Smad-3 and Smad-4 may determine the level of viral gene activation by Tat.
In this report, we present evidence for cooperativity between TGF␤ signaling regulators, including Smad-3 and Smad-4, and C/EBP transcription factor in modulation of HIV-1 LTR promoter activity. Earlier studies showed that expression of C/EBP enhances transcriptional activity of LTR in macrophages/monocytes (Henderson et al., 1995) . Further, it was demonstrated that C/EBP is required for HIV-1 replication in monocytic cells, and that the C/EBP-binding site within the LTR is pivotal for its function (Henderson et al., 1996) . In more FIG. 6. Effect of Smads on Tat activation of the LTR. U-87MG cells were transfected with 2 g of full-length LTR CAT plasmid (Ϫ450 to ϩ80) in the absence or presence of 0.5 g of a plasmid expressing Tat along with Smad-3 and Smad-4 expression plasmid as described in the legend to Fig. 1 . CAT enzymatic activity was determined after 48 h and the quantitative values were obtained as described in the legends to the previous figures. recent reports, evidence was provided for the importance of C/EBP in determining LTR transcriptional activity during invasion and maintenance of the virus in the CNS (Ross et al., 2001a,b) . Activation of the viral promoter which results in the production of several viral regulatory proteins, such as Tat, can potentiate the expression of several important cytokines and immunomodulators which through signal transduction pathways may affect expression of several cellular and viral genes. The most studied pathway which mutually communicates with both virus and host cells includes tumor necrosis factor alpha (TNF␣) whose level is increased upon viral infection (Smith et al., 1992) , and by autocrine and paracrine mechanisms triggering signaling that eventually results in activation of NF-B subunits of transcription factors (Rostasy et al., 2000) . Binding of the active NF-B p50/ p65 to the B motif of the LTR and their interaction with the other regulatory proteins, in turn, maximizes the expression of the viral genome (Perkins et al., 1993) . The TGF␤ signaling pathway, which is also activated by HIV-1 in astrocytic cells, can exert a similar effect on viral gene transcription via its regulatory proteins such as Smad-3, and Smad-4. Our data demonstrate that ectopic production of Smad-3 and Smad-4 in astrocytic cells positively and negatively regulates transcriptional activity of the viral promoter. Further, our data indicate that coproduction of Smad-3 and -4 results in a decrease in the activity of Smad-3 upon the viral promoter, suggesting that intracellular levels of these two factors may determine their activities upon the LTR transcription. The observation on the negative effect of Smad-3 and Smad-4 on LTR transcription corroborates with the earlier reports on suppression of HIV-1 replication by TGF␤-1 in infected cells of monocytic/macrophage lineage (Poli et al., 1991) . While the mechanism involved in Smad's regulation of HIV-1 gene transcription is not fully understood, one may postulate that association of Smad-3 with another activator protein in astrocytes can elevate its activity and that Smad-4 by disturbing this interaction moderates the activity of Smad-3. This observation is interesting in light of the earlier reports on the activation of type VII collagen promoter in cells coproducing Smad-3 and Smad-4 (Vindevoghel et al., 1998) pointing to the diverse activity of these factors on different promoters. It is also noteworthy that the activity of Smad-3 and Smad-4 can be modulated by other activators such as AP-1 and c-jun (Wong et al., 1999) . In a more recent study, it was shown that association of Smads with AP-1 confers TGF␤-1 responsiveness in a promoter-specific manner (Verrechia et al., 2001; Zhang et al., 1998) . Also, it is noteworthy that AP1 by associating with NF-B can stimulate the HIV-1 LTR (Jung et al., 1995) . Therefore, it seems that AP1 may play a dual role in the regulation of the LTR via the TGF␤/ Smad-3 and TNF␣/NF-B pathways. Our data presented in Figs. 3 and 5 demonstrate that Smad-3 and Smad-4 functionally and physically interact with C/EBP. One im-pact of such interaction is dissociation of C/EBP from its DNA target sequence located within the HIV-1 LTR in cells expressing Smad-3 and Smad-4. This event can temper the ability of C/EBP to stimulate viral promoter via its binding to the DNA sequences. This is in agreement with the recent reports on the ability of Smad proteins in suppressing C/EBP DNA-binding activity and its ability to stimulate haptoglobin gene expression (Zauberman et al., 2001) . Our more recent results unraveled an alternative mechanism whereby C/EBP can elevate transcription of several cellular and viral genes which do not contain C/EBP-binding sites, suggesting that C/EBP by increasing the levels and/or activity of other general activators, such as Sp1 and TBP, may also have an indirect regulatory impact on transcription of eukaryotic promoters (Coyle-Rink, unpublished observations). The ability of Smads to dissociate C/EBP from its DNA-binding sites without being associated with the DNA complex suggests an off DNA association of C/EBP and Smad proteins. In fact, our results from GST pull-down and immunoprecipitation/Western blot analyses indicate the interaction of C/EBP with Smad-4. Also, our results demonstrate that in the presence of Tat, the effect of Smads on the transcription of the HIV-1 promoter can be altered. The functional interaction of Tat and Smads, in particular, Smad-4, is of particular interest indicating that Tat, by inhibiting a negative effector such as Smad-4, may indirectly enhance viral gene transcription. Smad-3, on the other hand, can somewhat stimulate viral gene expression even in the presence of the strong positive effector protein, Tat.
Clearly, regulation of LTR transcription is mediated through complex signaling pathways that may function differentially in various cellular contexts. Our efforts on utilizing astrocytes, where the HIV-1 genome is weakly expressed compared to peripheral cells, unravels several regulatory mechanisms involving various pathways that prevent high level expression of the viral promoter and replication of the viral genome. Currently, we are focusing our attention on understanding the interaction of viral transactivator, Tat, with the various signaling pathways that exhibit regulatory effects on LTR gene transcription.
